eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
4/2024
vol. 11
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł oryginalny

Cyberchondria and health anxiety in allergy and immunology

Recep Evcen
1
,
Fatih Çölkesen
2
,
Eray Yıldız
3
,
Filiz Sadi Aykan
4
,
Mehmet Kılınç
5
,
Tuğba Önalan
2
,
Fatma Arzu Akkuş
2
,
Şevket Arslan
2

  1. Department of Clinical Immunology and Allergy, Recep Tayyip Erdogan University, Education and Research Hospital, Rize, Turkey
  2. Department of Clinical Immunology and Allergy, Necmettin Erbakan University, Faculty of Medicine, Konya, Turkey
  3. Department of Clinical Immunology and Allergy, Necip Fazıl City Hospital, Kahramanmaraş, Turkey
  4. Department of Clinical Immunology and Allergy, Gülhane Training and Research Hospital, Health Sciences University, Ankara, Turkey
  5. Department of Clinical Immunology and Allergy, Batman Education and Research Hospital, Batman, Turkey
Alergologia Polska – Polish Journal of Allergology 2024; 11, 4: 292–298
Data publikacji online: 2024/11/21
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Introduction:
The widespread use of the internet has made health information more accessible. However, it has also increased problems such as health anxiety and cyberchondria.

Aim:
This study aimed to assess cyberchondria levels in allergy and immunology clinic patients and examine the relationship between cyberchondria and health anxiety.

Material and methods:
This study was conducted on patients diagnosed with allergic disorders, chronic urticaria, hereditary angioedema (HAE), and primary immunodeficiency (PID). Cyberchondria severity was assessed using the Cyberchondria Severity Scale (CSS-12), while health anxiety was evaluated using the Short Health Anxiety Inventory (SHAI).

Results:
A total of 550 patients were included in the study, with 71% of the participants being female. The highest CSS-12 scores were observed in the HAE group (33.5 ±8.8), followed by the PID group (28.4 ±8.6). The allergic disorders group had the lowest level of cyberchondria severity (27.7 ±8.5). According to SHAI scores, PID and HAE groups had the highest values. A significant positive relationship was found between cyberchondria and health anxiety (r(548) = 0.416, p < 0.001).

Conclusions:
An increase in cyberchondria raises health anxiety and disease burden among allergy and immunology patients. Therefore, physicians should take this into account when treating these patients.



© 2025 Termedia Sp. z o.o.
Developed by Bentus.